pik-her2 cell
Cell therapyexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2015 (NCT02632201)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, passive
Tumor antigens immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pik-her2 cell
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02632201 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2015 | Eastern Hepatobiliary Surgery Hospital, People's Liberation Army of China |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eastern Hepatobiliary Surgery Hospital | Academic/Hospital | 1 | 0 | 1 | 2015 |
| People's Liberation Army of China | Government | 1 | 1 | 1 | 2015 |
2 organizations
Page 1 / 1